Sfoglia per Autore
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement
2009-01-01 Giordano R; Marzotti S; Balbo M; Romagnoli S; Marinazzo E; Berardelli R; Migliaretti G; Benso A; Falorni A; Ghigo E; Arvat E
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION
2010-01-01 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans
2010-01-01 R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; M. Balbo; L. Bonelli; R. Giordano; I. Karamouzis; M. Bo; E. Ghigo; E. Arvat
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS
2010-01-01 R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; R. Giordano; E. Ghigo; E. Arvat
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas
2010-01-01 R. Giordano; E. Marinazzo; R. Berardelli; A. Picu; M. Maccario; E. Ghigo; E. Arvat.
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans
2010-01-01 R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY
2011-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA
2011-01-01 R. Berardelli; L. Gianotti; I. Karamouzis; A. Picu; R. Giordano; V. D'Angelo; D. Zinnà; F. Lanfranco; E. Ghigo; E. Arvat
Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome.
2011-01-01 Karamouzis I1; Pervanidou P; Berardelli R; Iliadis S; Papassotiriou I; Karamouzis M; Chrousos GP; Kanaka-Gantenbein C.
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION
2011-01-01 R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE
2012-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; A. Brozzetti; V. D’Angelo; G. Mengozzi; G. Mandrile; D. Giachino; G. Migliaretti; V. Bini; A. Falorni; E. Ghigo; E. Arvat
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS
2013-01-01 R. Berardelli; I. Karamouzis; V. D’Angelo; C. Zichi; B. Fussotto; R. Giordano; E.Ghigo; E. Arvat
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS
2013-01-01 Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME
2013-01-01 R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE
2014-01-01 R. Giordano; F. Guaraldi; R. Berardelli; I Karamouzis; V. D’Angelo; C. Zichi; S. Grottoli; E. Ghigo; E. Arvat
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?
2014-01-01 Giustina A; Berardelli R; Gazzaruso C; Mazziotti G.
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas
2015-01-01 Karamouzis, I; Berardelli, R.; Prencipe, N.; Berton, A.; Bona, C.; Stura, G.; Corsico, M.; Gasco, V.; Maccario, M.; Ghigo, E.; Grottoli, S.
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome.
2015-01-01 I. Karamouzis; R. Berardelli; V. D'Angelo; B. Fussotto; C. Zichi; R. Giordano; F. Settanni; M. Maccario; E. Ghigo; E. Arvat
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY
2015-01-01 D'Angelo, V; Beccuti, G; Berardelli, R; Karamouzis, I; Zichi, C; Giordano, R; Minetto, Ma; Maccario, M; Ghigo, E; Arvat, E
SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS
2016-01-01 Guaraldi, F.; Karamouzis, I.; Berardelli, R.; D’Angelo, V.; Fumarola, F.; Rampino, A.; Zichi, C.; Ghigo and R Giordano, E. Ghigo and R. Giordano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement | 2009 | Giordano R; Marzotti S; Balbo M; Romagnoli S; Marinazzo E; Berardelli R; Migliaretti G; Benso A; Falorni A; Ghigo E; Arvat E | |
| METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION | 2010 | A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat | |
| Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans | 2010 | R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; M. Balbo; L. Bonelli; R. Giordano; I. Karamouzis; M. Bo; E. Ghigo; E. Arvat | |
| THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS | 2010 | R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; R. Giordano; E. Ghigo; E. Arvat | |
| Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas | 2010 | R. Giordano; E. Marinazzo; R. Berardelli; A. Picu; M. Maccario; E. Ghigo; E. Arvat. | |
| Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans | 2010 | R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat | |
| GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY | 2011 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat | |
| EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA | 2011 | R. Berardelli; L. Gianotti; I. Karamouzis; A. Picu; R. Giordano; V. D'Angelo; D. Zinnà; F. Lanfranco; E. Ghigo; E. Arvat | |
| Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. | 2011 | Karamouzis I1; Pervanidou P; Berardelli R; Iliadis S; Papassotiriou I; Karamouzis M; Chrousos GP; Kanaka-Gantenbein C. | |
| METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION | 2011 | R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat | |
| BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE | 2012 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; A. Brozzetti; V. D’Angelo; G. Mengozzi; G. Mandrile; D. Giachino; G. Migliaretti; V. Bini; A. Falorni; E. Ghigo; E. Arvat | |
| ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS | 2013 | R. Berardelli; I. Karamouzis; V. D’Angelo; C. Zichi; B. Fussotto; R. Giordano; E.Ghigo; E. Arvat | |
| THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS | 2013 | Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E | |
| ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME | 2013 | R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat | |
| DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE | 2014 | R. Giordano; F. Guaraldi; R. Berardelli; I Karamouzis; V. D’Angelo; C. Zichi; S. Grottoli; E. Ghigo; E. Arvat | |
| Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? | 2014 | Giustina A; Berardelli R; Gazzaruso C; Mazziotti G. | |
| Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas | 2015 | Karamouzis, I; Berardelli, R.; Prencipe, N.; Berton, A.; Bona, C.; Stura, G.; Corsico, M.; Gasco, V.; Maccario, M.; Ghigo, E.; Grottoli, S. | |
| Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | I. Karamouzis; R. Berardelli; V. D'Angelo; B. Fussotto; C. Zichi; R. Giordano; F. Settanni; M. Maccario; E. Ghigo; E. Arvat | |
| CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY | 2015 | D'Angelo, V; Beccuti, G; Berardelli, R; Karamouzis, I; Zichi, C; Giordano, R; Minetto, Ma; Maccario, M; Ghigo, E; Arvat, E | |
| SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS | 2016 | Guaraldi, F.; Karamouzis, I.; Berardelli, R.; D’Angelo, V.; Fumarola, F.; Rampino, A.; Zichi, C.; Ghigo and R Giordano, E. Ghigo and R. Giordano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile